These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 12718729)

  • 1. Transporters/receptors in the anterior chamber: pathways to explore ocular drug delivery strategies.
    Dey S; Anand BS; Patel J; Mitra AK
    Expert Opin Biol Ther; 2003 Feb; 3(1):23-44. PubMed ID: 12718729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanistic modeling of ophthalmic drug delivery to the anterior chamber by eye drops and contact lenses.
    Gause S; Hsu KH; Shafor C; Dixon P; Powell KC; Chauhan A
    Adv Colloid Interface Sci; 2016 Jul; 233():139-154. PubMed ID: 26318359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comprehensive insight on ocular pharmacokinetics.
    Agrahari V; Mandal A; Agrahari V; Trinh HM; Joseph M; Ray A; Hadji H; Mitra R; Pal D; Mitra AK
    Drug Deliv Transl Res; 2016 Dec; 6(6):735-754. PubMed ID: 27798766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug transport in corneal epithelium and blood-retina barrier: emerging role of transporters in ocular pharmacokinetics.
    Mannermaa E; Vellonen KS; Urtti A
    Adv Drug Deliv Rev; 2006 Nov; 58(11):1136-63. PubMed ID: 17081648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pharmacokinetic model for ocular drug delivery.
    Tojo K
    Chem Pharm Bull (Tokyo); 2004 Nov; 52(11):1290-4. PubMed ID: 15516748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of xenobiotic transporters in ophthalmic drug delivery.
    Chemuturi N; Yanez JA
    J Pharm Pharm Sci; 2013; 16(5):683-707. PubMed ID: 24393552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ophthalmic drug delivery considerations at the cellular level: drug-metabolising enzymes and transporters.
    Attar M; Shen J; Ling KH; Tang-Liu D
    Expert Opin Drug Deliv; 2005 Sep; 2(5):891-908. PubMed ID: 16296785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transporters and receptors in ocular drug delivery: opportunities and challenges.
    Dey S; Mitra AK
    Expert Opin Drug Deliv; 2005 Mar; 2(2):201-4. PubMed ID: 16296747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug delivery to the retina: challenges and opportunities.
    Duvvuri S; Majumdar S; Mitra AK
    Expert Opin Biol Ther; 2003 Feb; 3(1):45-56. PubMed ID: 12718730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular Drug Delivery - New Strategies for Targeting Anterior and Posterior Segments of the Eye.
    Fangueiro JF; Veiga F; Silva AM; Souto EB
    Curr Pharm Des; 2016; 22(9):1135-46. PubMed ID: 26675225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression, activity and pharmacokinetic impact of ocular transporters.
    Vellonen KS; Hellinen L; Mannermaa E; Ruponen M; Urtti A; Kidron H
    Adv Drug Deliv Rev; 2018 Feb; 126():3-22. PubMed ID: 29248478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PLGA-PEG-PLGA hydrogel for ocular drug delivery of dexamethasone acetate.
    Gao Y; Sun Y; Ren F; Gao S
    Drug Dev Ind Pharm; 2010 Oct; 36(10):1131-8. PubMed ID: 20334543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent Advances in Topical Ocular Drug Delivery.
    Yellepeddi VK; Palakurthi S
    J Ocul Pharmacol Ther; 2016 Mar; 32(2):67-82. PubMed ID: 26666398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colloidal drug delivery system: amplify the ocular delivery.
    Ali J; Fazil M; Qumbar M; Khan N; Ali A
    Drug Deliv; 2016; 23(3):710-26. PubMed ID: 24892625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled and continuous release ocular drug delivery systems: pros and cons.
    Abdelkader H; Alany RG
    Curr Drug Deliv; 2012 Jul; 9(4):421-30. PubMed ID: 22640036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanotechnology in ocular drug delivery.
    Sahoo SK; Dilnawaz F; Krishnakumar S
    Drug Discov Today; 2008 Feb; 13(3-4):144-51. PubMed ID: 18275912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular delivery systems for topical application of anti-infective agents.
    Duxfield L; Sultana R; Wang R; Englebretsen V; Deo S; Rupenthal ID; Al-Kassas R
    Drug Dev Ind Pharm; 2016 Jan; 42(1):1-11. PubMed ID: 26325119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of membrane transporters and metabolizing enzymes in ocular drug delivery.
    Vadlapatla RK; Vadlapudi AD; Pal D; Mitra AK
    Curr Drug Metab; 2014; 15(7):680-93. PubMed ID: 25255873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal solute carriers: an overview of trends and strategies for improving oral drug absorption.
    Steffansen B; Nielsen CU; Brodin B; Eriksson AH; Andersen R; Frokjaer S
    Eur J Pharm Sci; 2004 Jan; 21(1):3-16. PubMed ID: 14706808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic implications of nanomedicine for ocular drug delivery.
    Meng T; Kulkarni V; Simmers R; Brar V; Xu Q
    Drug Discov Today; 2019 Aug; 24(8):1524-1538. PubMed ID: 31102733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.